1[1]Thompson JS,Thacker LR.CREG Matehing for first cadaveric kianey transplants(TNX) performed by SEOPE centers between 1987 and 1995.Clin Transplant,1996,10:586～593
2[2]Gebel HM,Haris SB,2ibari G,et al.Conundrums with flow PRA bead.Clin Transplant,2002,16 (Suppl 7):24～29
3[3]Fuller AA,Trevithick JE,Herzenbert LA,et al.Topographic map of the HLA-A2 CREG epitopes using human alloantibodies probes.Hum Immunol,1990,28:284～289
4[4]Takemoto S,Gjertson DW,Terasaki PI.HLA matching:a comparison of conventional and molecular approaches.In:Terasaki PI,Cecka J M,eds.Clincal transplants.Los Angeles:UCLA Tissue Typing Laboratory,1992,413～419
5[5]Rodey GE,Neylan JF,Whelchel JD,et al.epitope specincity of HLA class I alloantibodies.I.Frequency analysis of antibodies to private versus publiC specifities in potential transplant recipients.Hum Immunol,1994,39:272 ～ 279
6[6]Rodey GE,Fuller TC.Public epitopes and the antigenic structure of the HLA molecules.CRC Crit Rev Immunol,1987,7:229～237
7[7]Collins RW,Harmer AW,Heads AJ,et al.The clinical importance of vanation within the HLA-Bw4 complex.Transplantation,2001,72:1851～ 1853
8[8]Konoeda Y,Terasaki PI,Wakisaka A,et al.Public determinants of HLA indicated by pregnancy antibodies.Transplantation,1986,41:253～261
9[9]Thompson JS,Thacker LR.CREG Marching for first cadaveric kidney transplants(TNX) performed by SEOPE centers between 1987and 1995:An analysis of outcome and prospective benefit.Transplant-proc,1997,29:1435 ～ 1438
10[10]Yvo WJ.Supkens,Ilias I.N.Doxiadis,Johan W.de Fijere et al.Shareing cross-reactive groups of MHC class I improves lomg-term graft survival.Kmdney International,1999,56:1920～ 1927
